Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

10.97USD
17 Oct 2014
Price Change (% chg)

$0.08 (+0.73%)
Prev Close
$10.89
Open
$11.46
Day's High
$11.89
Day's Low
$10.75
Volume
8,042,578
Avg. Vol
6,022,734
52-wk High
$13.80
52-wk Low
$2.26

Search Stocks
Domain Partners Viii L P Options Exercised: 0
Trade Date: Thursday, 17 Jan 2013 Price: 0.00
Title: Beneficial Owner of More than 10% Class Shares Held: 5,772,968
Type Traded: Direct Net Change in Shares This Filing: -1,000,000

Institutional Holders

% Shares Owned: 85.07%
# of Holders: 150
Total Shares Held: 83,188,633
3 Mo. Net Change: -14,891,117
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 13
# Net Buyers: -3

Officers & Directors

Name Age Since Current Position

David Scheer

61 2010 Chairman of the Board

Milind Deshpande

57 2013 President, Chief Executive Officer, Director

Mary Kay Fenton

50 2010 Chief Financial Officer, Senior Vice President

Gautam Shah

57 2012 Executive Vice President, Chief Compliance Officer

David Apelian

48 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

49 2012 Senior Vice President, Chief Commercial Officer

Michael Kishbauch

65 2013 Director

Jason Fisherman

56 2000 Independent Director

Gary Frashier

75 2008 Independent Director

Kurt Graves

46 2012 Independent Director

Dennis Liotta

66 2008 Independent Director

Robert Van Nostrand

57 2007 Independent Director

Nicole Vitullo

54 2010 Independent Director
Search Stocks